These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

619 related items for PubMed ID: 18388514

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Combination treatment strategies in early rheumatoid arthritis.
    Suresh E, Lambert CM.
    Ann Rheum Dis; 2005 Sep; 64(9):1252-6. PubMed ID: 15860511
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Drug Insight: resistance to methotrexate and other disease-modifying antirheumatic drugs--from bench to bedside.
    van der Heijden JW, Dijkmans BA, Scheper RJ, Jansen G.
    Nat Clin Pract Rheumatol; 2007 Jan; 3(1):26-34. PubMed ID: 17203006
    [Abstract] [Full Text] [Related]

  • 25. Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies.
    Saunders SA, Capell HA, Stirling A, Vallance R, Kincaid W, McMahon AD, Porter DR.
    Arthritis Rheum; 2008 May; 58(5):1310-7. PubMed ID: 18438851
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Disease-modifying antirheumatic drugs.
    Conaghan PG, Lehmann T, Brooks P.
    Curr Opin Rheumatol; 1997 May; 9(3):183-90. PubMed ID: 9204252
    [Abstract] [Full Text] [Related]

  • 32. Disease-modifying Antirheumatic Drugs (DMARD) and Combination Therapy of Conventional DMARD in Patients with Spondyloarthritis and Psoriatic Arthritis with Axial Involvement.
    Simone D, Nowik M, Gremese E, Ferraccioli GF.
    J Rheumatol Suppl; 2015 Nov; 93():65-9. PubMed ID: 26523061
    [Abstract] [Full Text] [Related]

  • 33. Leflunomide in clinical practice. A retrospective observational study on use of leflunomide in New Zealand.
    Jagoda JS, Rajapakse CN.
    Int J Rheum Dis; 2011 Oct; 14(4):340-4. PubMed ID: 22004230
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effects of biologic agents and other disease-modifying antirheumatic drugs on cardiovascular outcomes in psoriasis and psoriatic arthritis: a systematic review.
    Armstrong AW, Brezinski EA, Follansbee MR, Armstrong EJ.
    Curr Pharm Des; 2014 Oct; 20(4):500-12. PubMed ID: 23565631
    [Abstract] [Full Text] [Related]

  • 40. Combination therapy with multiple disease-modifying antirheumatic drugs in rheumatoid arthritis: a preventive strategy.
    Pincus T, O'Dell JR, Kremer JM.
    Ann Intern Med; 1999 Nov 16; 131(10):768-74. PubMed ID: 10577301
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.